CLDX

Celldex Therapeutics, Inc.

Healthcare›Biotechnology|NASDAQ Capital Market|US

Price

$31.06

Market Cap

$2.07B

Beta

1.20

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)-78.63%

EPS Growth (YoY)-59.18%

Revenue CAGR 3Y-13.98%

P/E Ratio0.0

PEG Ratio—

FCF Yield-10.32%

Debt / Equity0.00

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for CLDX.